Cargando…

Distribution of tumor-infiltrating immune cells in glioblastoma

AIM: Evaluation of features related to infiltrating immune cell level in glioblastoma. METHODS: Tumor-infiltrating lymphocytes (TILs) through H&E staining, and TILs (CD3, CD4, CD8 and CD20) and macrophage (CD68 and CD163) levels through immunohistochemistry were evaluated through digital analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Orrego, Enrique, Castaneda, Carlos A, Castillo, Miluska, Bernabe, Luis A, Casavilca, Sandro, Chakravarti, Arnab, Meng, Wei, Garcia-Corrochano, Pamela, Villa-Robles, Maria R, Zevallos, Rocio, Mejia, Omar, Deza, Pedro, Belmar-Lopez, Carolina, Ojeda, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331699/
https://www.ncbi.nlm.nih.gov/pubmed/30299157
http://dx.doi.org/10.2217/cns-2017-0037
_version_ 1783387185780621312
author Orrego, Enrique
Castaneda, Carlos A
Castillo, Miluska
Bernabe, Luis A
Casavilca, Sandro
Chakravarti, Arnab
Meng, Wei
Garcia-Corrochano, Pamela
Villa-Robles, Maria R
Zevallos, Rocio
Mejia, Omar
Deza, Pedro
Belmar-Lopez, Carolina
Ojeda, Luis
author_facet Orrego, Enrique
Castaneda, Carlos A
Castillo, Miluska
Bernabe, Luis A
Casavilca, Sandro
Chakravarti, Arnab
Meng, Wei
Garcia-Corrochano, Pamela
Villa-Robles, Maria R
Zevallos, Rocio
Mejia, Omar
Deza, Pedro
Belmar-Lopez, Carolina
Ojeda, Luis
author_sort Orrego, Enrique
collection PubMed
description AIM: Evaluation of features related to infiltrating immune cell level in glioblastoma. METHODS: Tumor-infiltrating lymphocytes (TILs) through H&E staining, and TILs (CD3, CD4, CD8 and CD20) and macrophage (CD68 and CD163) levels through immunohistochemistry were evaluated through digital analysis. RESULTS: CD68 (9.1%), CD163 (2.2%), CD3 (1.6%) and CD8 (1.6%) had the highest density. Higher CD4(+) was associated with unmethylated MGMT (p = 0.016). Higher CD8(+) was associated with larger tumoral size (p = 0.027). Higher CD163(+) was associated with higher age (p = 0.044) and recursive partitioning analysis = 4. Women (p < 0.05), total resection (p < 0.05), MGMT-methylation (p < 0.001), radiotherapy (p < 0.001), chemotherapy (p < 0.001) and lower CD4(+) (p < 0.05) were associated with longer overall survival. CONCLUSION: Macrophages are more frequent than TILs. Some subsets are associated with clinical features.
format Online
Article
Text
id pubmed-6331699
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-63316992019-01-16 Distribution of tumor-infiltrating immune cells in glioblastoma Orrego, Enrique Castaneda, Carlos A Castillo, Miluska Bernabe, Luis A Casavilca, Sandro Chakravarti, Arnab Meng, Wei Garcia-Corrochano, Pamela Villa-Robles, Maria R Zevallos, Rocio Mejia, Omar Deza, Pedro Belmar-Lopez, Carolina Ojeda, Luis CNS Oncol Research Article AIM: Evaluation of features related to infiltrating immune cell level in glioblastoma. METHODS: Tumor-infiltrating lymphocytes (TILs) through H&E staining, and TILs (CD3, CD4, CD8 and CD20) and macrophage (CD68 and CD163) levels through immunohistochemistry were evaluated through digital analysis. RESULTS: CD68 (9.1%), CD163 (2.2%), CD3 (1.6%) and CD8 (1.6%) had the highest density. Higher CD4(+) was associated with unmethylated MGMT (p = 0.016). Higher CD8(+) was associated with larger tumoral size (p = 0.027). Higher CD163(+) was associated with higher age (p = 0.044) and recursive partitioning analysis = 4. Women (p < 0.05), total resection (p < 0.05), MGMT-methylation (p < 0.001), radiotherapy (p < 0.001), chemotherapy (p < 0.001) and lower CD4(+) (p < 0.05) were associated with longer overall survival. CONCLUSION: Macrophages are more frequent than TILs. Some subsets are associated with clinical features. Future Medicine Ltd 2018-10-09 /pmc/articles/PMC6331699/ /pubmed/30299157 http://dx.doi.org/10.2217/cns-2017-0037 Text en © 2018 Orrego, Castaneda, Castillo et al. This work is licensed under a Creative Commons Attribution-NonCommercial NonDerivative 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Research Article
Orrego, Enrique
Castaneda, Carlos A
Castillo, Miluska
Bernabe, Luis A
Casavilca, Sandro
Chakravarti, Arnab
Meng, Wei
Garcia-Corrochano, Pamela
Villa-Robles, Maria R
Zevallos, Rocio
Mejia, Omar
Deza, Pedro
Belmar-Lopez, Carolina
Ojeda, Luis
Distribution of tumor-infiltrating immune cells in glioblastoma
title Distribution of tumor-infiltrating immune cells in glioblastoma
title_full Distribution of tumor-infiltrating immune cells in glioblastoma
title_fullStr Distribution of tumor-infiltrating immune cells in glioblastoma
title_full_unstemmed Distribution of tumor-infiltrating immune cells in glioblastoma
title_short Distribution of tumor-infiltrating immune cells in glioblastoma
title_sort distribution of tumor-infiltrating immune cells in glioblastoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331699/
https://www.ncbi.nlm.nih.gov/pubmed/30299157
http://dx.doi.org/10.2217/cns-2017-0037
work_keys_str_mv AT orregoenrique distributionoftumorinfiltratingimmunecellsinglioblastoma
AT castanedacarlosa distributionoftumorinfiltratingimmunecellsinglioblastoma
AT castillomiluska distributionoftumorinfiltratingimmunecellsinglioblastoma
AT bernabeluisa distributionoftumorinfiltratingimmunecellsinglioblastoma
AT casavilcasandro distributionoftumorinfiltratingimmunecellsinglioblastoma
AT chakravartiarnab distributionoftumorinfiltratingimmunecellsinglioblastoma
AT mengwei distributionoftumorinfiltratingimmunecellsinglioblastoma
AT garciacorrochanopamela distributionoftumorinfiltratingimmunecellsinglioblastoma
AT villaroblesmariar distributionoftumorinfiltratingimmunecellsinglioblastoma
AT zevallosrocio distributionoftumorinfiltratingimmunecellsinglioblastoma
AT mejiaomar distributionoftumorinfiltratingimmunecellsinglioblastoma
AT dezapedro distributionoftumorinfiltratingimmunecellsinglioblastoma
AT belmarlopezcarolina distributionoftumorinfiltratingimmunecellsinglioblastoma
AT ojedaluis distributionoftumorinfiltratingimmunecellsinglioblastoma